<![CDATA[Crown Bioscience Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=26708>Thu, 16 Apr 2026 00:41:44 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities]]>https://www.newswire.co.kr/newsRead.php?no=1027308Wed, 21 Jan 2026 15:20:00 +0900<![CDATA[크라운 바이오사이언스 샌디에이고 연구소, CLIA 인증 이어 CAP 인증 획득… 임상 등급 역량 확대]]>https://www.newswire.co.kr/newsRead.php?no=1027309Wed, 21 Jan 2026 15:20:00 +0900<![CDATA[Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory]]>https://www.newswire.co.kr/newsRead.php?no=1021871Fri, 31 Oct 2025 10:15:00 +0900<![CDATA[크라운 바이오사이언스, 수저우 연구소에서 2025년 두 번째 CLIA 인증 획득]]>https://www.newswire.co.kr/newsRead.php?no=1021872Fri, 31 Oct 2025 10:15:00 +0900<![CDATA[Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation]]>https://www.newswire.co.kr/newsRead.php?no=1018668Fri, 12 Sep 2025 16:20:00 +0900<![CDATA[메디신스 디스커버리 캐터펄트-크라운 바이오사이언스, 방사성의약품 혁신 위한 전략적 글로벌 제휴]]>https://www.newswire.co.kr/newsRead.php?no=1018669Fri, 12 Sep 2025 16:20:00 +0900<![CDATA[Crown Bioscience Appoints John Gu as Chief Executive Officer]]>https://www.newswire.co.kr/newsRead.php?no=1007562Fri, 14 Mar 2025 16:50:00 +0900<![CDATA[크라운 바이오사이언스, 최고경영자에 존 구 임명]]>https://www.newswire.co.kr/newsRead.php?no=1007563Fri, 14 Mar 2025 16:50:00 +0900<![CDATA[Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities]]>https://www.newswire.co.kr/newsRead.php?no=997865Wed, 02 Oct 2024 13:45:00 +0900<![CDATA[크라운 바이오사이언스, 첨단 종양학 모델 및 이미징 기능으로 싱가포르 시설 확장]]>https://www.newswire.co.kr/newsRead.php?no=997867Wed, 02 Oct 2024 13:45:00 +0900<![CDATA[Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row]]>https://www.newswire.co.kr/newsRead.php?no=986173Tue, 19 Mar 2024 14:55:00 +0900<![CDATA[크라운 바이오사이언스, 3년 연속 ‘T+ Employer®’ 인증]]>https://www.newswire.co.kr/newsRead.php?no=986174Tue, 19 Mar 2024 14:55:00 +0900<![CDATA[Crown Bioscience’s Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations]]>https://www.newswire.co.kr/newsRead.php?no=983137Wed, 24 Jan 2024 15:20:00 +0900<![CDATA[크라운 바이오사이언스의 글로벌 종양학 연구시설, 권위 있는 ISO 및 CAP 인증 획득]]>https://www.newswire.co.kr/newsRead.php?no=983138Wed, 24 Jan 2024 15:20:00 +0900<![CDATA[Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening]]>https://www.newswire.co.kr/newsRead.php?no=978280Wed, 08 Nov 2023 16:55:00 +0900<![CDATA[크라운 바이오사이언스, OrganoidXplore 출시… 신속한 대규모 오가노이드 약물 스크리닝 통한 암 연구 혁신]]>https://www.newswire.co.kr/newsRead.php?no=978282Wed, 08 Nov 2023 16:55:00 +0900<![CDATA[Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials]]>https://www.newswire.co.kr/newsRead.php?no=972807Wed, 23 Aug 2023 13:15:00 +0900<![CDATA[Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank]]>https://www.newswire.co.kr/newsRead.php?no=960320Thu, 26 Jan 2023 10:40:00 +0900<![CDATA[Crown Bioscience, Indivumed의 서비스 비즈니스 및 지원 바이오뱅크 인수]]>https://www.newswire.co.kr/newsRead.php?no=960321Thu, 26 Jan 2023 10:40:00 +0900<![CDATA[Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents]]>https://www.newswire.co.kr/newsRead.php?no=957536Fri, 09 Dec 2022 09:15:51 +0900<![CDATA[New Crown Bioscience Publication Details Application of In Vitro 3D Organoids with Matched PDX for Clinically Relevant Oncology Drug Development]]>https://www.newswire.co.kr/newsRead.php?no=957088Fri, 02 Dec 2022 15:25:00 +0900<![CDATA[크라운 바이오사이언스, 임상적으로 유의한 종양학 약물 개발 위해 PDX 시험관 내 3D 오르가노이드 적용 다룬 논문 발표]]>https://www.newswire.co.kr/newsRead.php?no=957089Fri, 02 Dec 2022 15:25:00 +0900<![CDATA[Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’ to Improve Response Predictability to Immuno-Oncology Drug Candidates]]>https://www.newswire.co.kr/newsRead.php?no=931925Fri, 08 Oct 2021 17:15:00 +0900<![CDATA[크라운 바이오사이언스, 면역 종양학 신약 후보 물질 반응 예측성 위한 ‘3D Ex Vivo 환자 조직 플랫폼’ 출범]]>https://www.newswire.co.kr/newsRead.php?no=931926Fri, 08 Oct 2021 17:15:00 +0900<![CDATA[Crown Bioscience Invests in Commercial Leadership]]>https://www.newswire.co.kr/newsRead.php?no=927438Wed, 21 Jul 2021 10:55:00 +0900